Mangalam Drugs And Organics Limited has informed the Exchange regarding Resignation of Mr Ajay Avinash Samant as Chief Financial Officer of the company w.e.f. January 31, 2026.
MANGALAM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mangalam Drugs And Organics Limited has informed the stock exchange about the resignation of Mr Ajay Avinash Samant from the position of Chief Financial Officer (CFO) of the company. The resignation will take effect from January 31, 2026. The company has not yet announced a replacement for the CFO role. This is a key managerial personnel (KMP) change at the finance leadership level.
The departure of the CFO could create short-term uncertainty around financial reporting and strategic decision-making until a successor is appointed. Shareholders should watch for further announcements regarding the appointment of a new CFO, which could influence investor confidence in the company's financial governance.